易方达标普生物科技人民币C(012866)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-12-31 | CERE | Cerevel Therapeutics Holdings Inc | 274.78 | 0.85% |
| 2022-12-31 | BEAM | Beam Therapeutics Inc | 273.34 | 0.84% |
| 2022-12-31 | BLUE | 蓝鸟生物 | 271.97 | 0.84% |
| 2022-12-31 | BPMC | Blueprint Medicines Corp | 272.41 | 0.84% |
| 2022-12-31 | IOVA | Iovance Biotherapeutics Inc | 271.26 | 0.84% |
| 2022-12-31 | MYOV | Myovant Sciences Ltd | 272.45 | 0.84% |
| 2022-12-31 | VRTX | 福泰制药 | 272.32 | 0.84% |
| 2022-12-31 | NTLA | Intellia Therapeutics Inc | 269.8 | 0.83% |
| 2022-12-31 | VERV | Verve Therapeutics Inc | 263.1 | 0.81% |
| 2022-12-31 | RLAY | Relay Therapeutics Inc | 256.8 | 0.79% |
| 2022-12-31 | DVAX | 德纳维制药 | 251.16 | 0.77% |
| 2022-12-31 | EDIT | Editas Medicine Inc | 249.45 | 0.77% |
| 2022-12-31 | IMGN | ImmunoGen Inc | 247.7 | 0.76% |
| 2022-12-31 | MNKD | 曼恩凯德生物医疗 | 246.65 | 0.76% |
| 2022-12-31 | SNDX | Syndax Pharmaceuticals Inc | 245.72 | 0.76% |
| 2022-12-31 | TVTX | Travere Therapeutics Inc | 245.34 | 0.76% |
| 2022-12-31 | CRSP | CRISPR Therapeutics AG | 244.27 | 0.75% |
| 2022-12-31 | VCYT | Veracyte Inc | 244.05 | 0.75% |
| 2022-12-31 | CLDX | 塞德斯医疗 | 233.15 | 0.72% |
| 2022-12-31 | SAGE | Sage Therapeutics Inc | 228.12 | 0.7% |
公告&资料
